Edgar Filing: DEADY CONAN R

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

DEADY CONAN R

2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [IDXX]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Corp VP, General Counsel & Sec

(Last)

(First)

(Middle)

ONE IDEXX DRIVE

3. Date of Earliest Transaction (Month/Day/Year)
02/14/2013

(Street)

WESTBROOK, ME 04092

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	02/14/2013		M		3,449	A	$ 56.95	4,631	D
Common Stock	02/14/2013		M		2,401	A	$ 77.59	7,032	D
Common Stock	02/14/2013		M		3,772	A	$ 34.37	10,804	D
Common Stock	02/14/2013		S		9,622	D	$ 92.0428 ⁽¹⁾	1,182	D
Common Stock	02/14/2013		M		243	A	$ 0	1,425	D
Common Stock	02/14/2013		M		258	A	$ 0	1,683	D
Common Stock	02/14/2013		M		375	A	$ 0	2,058	D
Common Stock	02/14/2013		M		363	A	$ 0	2,421	D
Common Stock	02/14/2013		M		300	A	$ 0	2,721	D
Common Stock	02/14/2013		F		496	D	$ 91.68	2,225	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Non-Qualified Stock Option (right to buy)

$ 56.95

02/14/2013

1,693

⁽²⁾

02/13/2015

Common Stock

1,693

$ 0

Non-Qualified Stock Option (right to buy)

$ 77.59

02/14/2013

2,401

⁽³⁾

02/13/2018

Common Stock

2,401

$ 0

5,914

Non-Qualified Stock Option (right to buy)

$ 34.37

02/14/2013

3,772

⁽⁴⁾

02/13/2016

Common Stock

3,772

$ 0

863

Incentive Stock Option (right to buy)

$ 56.95

02/14/2013

1,756

⁽⁵⁾

02/13/2015

Common Stock

1,756

$ 0

Restricted Stock Unit

⁽⁶⁾

02/14/2013

243

⁽⁶⁾

Common Stock

243

$ 0

4,154

Restricted Stock Unit

⁽⁷⁾

02/14/2013

258

⁽⁷⁾

Common Stock

258

$ 0

3,896

Restricted Stock Unit

⁽⁸⁾

02/14/2013

375

⁽⁸⁾

Common Stock

375

$ 0

3,521

Restricted Stock Unit

⁽⁹⁾

02/14/2013

363

⁽⁹⁾

Common Stock

363

$ 0

3,158

Restricted Stock Unit

⁽¹⁰⁾

02/14/2013

300

⁽¹⁰⁾

Common Stock

300

$ 0

2,858

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
DEADY CONAN R ONE IDEXX DRIVE WESTBROOK, ME 04092			Corp VP, General Counsel & Sec

Signatures

Conan R. Deady		02/19/2013
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $92.00 to $92.10, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
(2)	Grant of options to buy shares of common stock becomes exercisable as to 3,449 shares on 02/14/2009 and 02/14/2010, 3,448 shares on 02/14/2011 and 02/14/2012, and the remaining 1,693 shares on 02/14/2013.
(3)	Grant of options to buy shares of common stock becomes exercisable as to 2,401 shares on 02/14/2012, 02/14/2013, 02/14/2014 and 02/14/2015, and the remaining 1,112 shares on 02/14/2016.
(4)	Grant of options to buy shares of common stock becomes exercisable as to 3,772 shares on 02/14/2010 and 02/14/2013, 3,773 shares on 02/14/2011 and 02/14/2012, and the remaining 863 shares on 02/14/2014.
(5)	Grant of options to buy shares of common stock becomes exercisable as to 1 share on 02/14/2011, and the remaining 1,755 shares on 02/14/2013.
(6)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
(7)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
(8)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
(9)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
(10)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.